Titlebook: Cardiac Markers; Alan H. B. Wu Book 2003Latest edition Springer Science+Business Media New York 2003 Laboratory.Laboratory Medicine.Lipopr

Condyle

溫室

Contort

Cerumen

Evolution of Cardiac Markers in Clinical Trialspast, however, the value of biochemical markers was limited by their rather simplistic ability to categorize patients into one of two groups—those with myocardial infarctions (MI) and those without. Their initial place in clinical trials was therefore often confined to defining specific patient popu

Negligible

Assessing Reperfusion and Prognostic Infarct Sizing with Biochemical Markersocused on treatments aimed at limiting infarct size by improving myocardial oxygen supply, lowering myocardial oxygen demand, and minimizing autolytic damage to myocytes .,.. The thrombus became the primary therapeutic target for reperfusion therapy and monitoring because it is a keystone pathophysi

Antimicrobial